Literature DB >> 14568271

The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply?

Axel M Gressner, Ralf Weiskirchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14568271     DOI： 10.1016/s0168-8278(03)00432-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Lentiviral-mediated RNA interference against TGF-beta receptor type II in renal epithelial and fibroblast cell populations in vitro demonstrates regulated renal fibrogenesis that is more efficient than a nonlentiviral vector.

Authors:  Tao Yang; Bing Zhang; Betty K Pat; Ming Q Wei; Glenda C Gobe
Journal:  J Biomed Biotechnol       Date:  2010-11-28

Review 2.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

3.  Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options.

Authors:  Olav A Gressner; Ralf Weiskirchen; Axel M Gressner
Journal:  Comp Hepatol       Date:  2007-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.